The involvement of cyclic GMP in tyrosine aminotransferase degradation in rat hepatoma tissue culture cells.
Theophylline, a cyclic nucleotide phosphodiesterase inhibitor, increases the rate of tyrosine aminotransferase (TAT) degradation in rat hepatoma tissue culture (HTC) cells. Theophylline (0.1-10 mM) causes a two- to five-fold increase in intracellular cAMP concentration but a 30-60% decrease in cGMP concentration. The decrease in cGMP occurs at doses of theophylline which increase the rate of TAT degradation. When cGMP levels are increased by incubating the cells with either Mn2+, an activator of guanylate cyclase, or 8-bromo-cGMP, an analog of cGMP, the effect of theophylline is reversed and the rate of TAT degradation is slowed. Thus, the rate of TAT degradation is inversely related to the concentration of cGMP in HTC cells. This raises the possibility that a cGMP-dependent event is involved in the control of specific protein degradation.
D000818:Animals; D006152:Cyclic GMP / Q000031:analogs & derivatives / Q000494:pharmacology / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D066298:In Vitro Techniques; D008114:Liver Neoplasms, Experimental / Q000201:enzymology*; D008345:Manganese / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology; D051381:Rats; D013806:Theophylline / Q000494:pharmacology; D013997:Time Factors; D014444:Tyrosine Transaminase / Q000378:metabolism*
D010726:Phosphodiesterase Inhibitors; C016276:8-bromocyclic GMP; D008345:Manganese; D013806:Theophylline; D014444:Tyrosine Transaminase; D006152:Cyclic GMP